Shuaijun Li

Shuaijun Li


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2024 in Journal of Pharmaceutical Analysis
Verified
Journal Article
Open access
SJShuangmeng Jia
Shuangmeng Jia
JHJieshen Huang
Jieshen Huang
WLWuyan Lu
Wuyan Lu
YMYongen Miao
Yongen Miao
KHKehua Huang
Kehua Huang
JHJiefeng Huang
Jiefeng Huang
Skin flaps are frequently employed in plastic and reconstructive surgery to address tissue defects. However, their low survival rates remain a challenge, attributed to vascular crisis and necrosis. Despite numerous studies investigating drugs to alleviate flap necrosis, a comprehensive analysis of the research trend in this critical area is lacking. To gain a deeper understanding of the current status, research focal points, and future trends in drugs aimed at enhancing flap survival, a thorough retrospective analysis is imperative. This study aims to employ bibliometric methods to scrutinize the evolution, mechanisms, and forthcoming trends of drugs targeting flap survival improvement. Using VOSviewer software, we quantitatively and visually depict 1) annual temporal trends in the number of documents and citations; 2) national/regional publications and their collaborations; 3) institutional and authors’ contribution; 4) journal contribution and relevance; and 5) analysis of research hotspots and directions derived from keywords. Ultimately, we discussed the prospects and challenges of future advances and clinical translation of drugs designed to enhance skin flap survival. In conclusion, the field of pharmacology dedicated to improving skin flap survival is expanding, and this study aims to offer a fresh perspective to promote the advancement and clinical application of such drugs.

21 January 2025 in Redox Biology
Verified
Journal Article
Open access
JHJiefeng Huang
Jiefeng Huang
WLWuyan Lu
Wuyan Lu
SZShenli Zhao
Shenli Zhao
ZCZixin Cai
Zixin Cai
LLLinxiao Li
Linxiao Li
SLShuaijun Li
Shuaijun Li
Skin fibrosis, characterized by uncontrolled secretion of extracellular matrix (ECM) proteins such as collagen, can lead to excessive scarring and compromised tissue function. Despite the widespread occurrence of fibrotic diseases, effective therapies are lacking. Recent clinical studies have demonstrated a positive correlation between serum homocysteine (Hcy) levels and the severity of systemic sclerosis. However, it remains unclear whether Hcy accumulation plays a pathogenic role in skin fibrosis. Here, we report that Hcy metabolism in fibroblasts plays a crucial role in regulating the pathogenesis of skin fibrosis. Fibrotic skin fibroblasts exhibited elevated levels of Hcy due to the downregulation of catabolism genes CBS and MTR. Experimental skin fibrosis was induced and exacerbated in mouse skin fibroblasts and tissues through adenoviral knockdown of Cbs or Mtr, whereas overexpression of these catabolic genes mitigated the pathogenesis. Furthermore, exogenous Hcy supplementation induced and aggravated the expression of inflammatory and fibrotic genes, promoting both spontaneous and BLM-induced skin fibrosis. Notably, folate administration enhanced Hcy catabolism and ameliorated skin inflammation and fibrosis by inhibiting JAK2/STAT3 signaling pathway. Collectively, these results indicate that skin fibrosis is associated with Hcy metabolic disorders and suggest that targeting Hcy metabolism or supplementing folate may provide a novel strategy for skin fibrosis.

24 September 2025 in Advanced Science
Verified
Journal Article
Open access
JHJiefeng Huang
Jiefeng Huang
KFKe Fang
Ke Fang
WLWuyan Lu
Wuyan Lu
RWRongrong Wu
Rongrong Wu
YCYuanyuan Chen
Yuanyuan Chen
SLShuaijun Li
Shuaijun Li
Idiopathic pulmonary fibrosis (IPF) is a lethal interstitial lung disease, marked by progressive extracellular matrix deposition, for which there are no effective treatments to halt disease progression. Although hyperhomocysteinemia is implicated in multiple pathological processes, its role in IPF remains largely unexplored. Through multiomics profiling of IPF patients, significantly elevated homocysteine (Hcy) concentrations in plasma and bronchoalveolar lavage fluid are identified compared to healthy controls. Single‐cell RNA sequencing and spatial transcriptomics reveal alveolar type 2 epithelial cells as the primary site of Hcy metabolism, with downregulation of Hcy‐catabolizing enzyme methionine synthase reductase ( MTRR ) during fibrotic progression. Genetic perturbation studies in murine models demonstrate that MTRR knockdown exacerbates bleomycin‐induced mortality and fibrosis, whereas MTRR overexpression exerts protective effects. Furthermore, Hcy supplementation initiates and accelerates pulmonary fibrosis development, while folate administration reduces pulmonary Hcy levels and alleviates fibrosis. Mechanistically, it is revealed that pathogenic hyperhomocysteinemia induces homocysteinylation–ubiquitination cascades that modify Syntaxin 17 (STX17) posttranslationally, leading to its proteasomal degradation and consequent impairment of autophagic flux. Notably, pharmacological folate administration reverses STX17 depletion, restoring autophagic flux and mitigating pulmonary fibrosis in mouse models. These findings collectively establish a Hcy–STX17–proteostasis axis wherein excess homocysteinylation creates a self‐reinforcing loop of autophagy dysfunction and fibrogenesis.

1 March 2025 in Tissue Engineering Part A
Verified
Journal Article
Closed access
HHHaotian Han
Haotian Han
ZZZhihua Zhou
Zhihua Zhou
TSTing Shang
Ting Shang
SLShuaijun Li
Shuaijun Li
XSXiang Shen
Xiang Shen
LCLei Cui
Lei Cui
Silk fibroin (SF) has garnered significant attention as a natural polymer for fabricating porous scaffolds in various engineering applications. However, the limited osteoinductive property of SF ha...

22 December 2025 in Cell Regeneration
Verified
Journal Article
Open access
PDF file
JHJiefeng Huang
Jiefeng Huang
SJShuangmeng Jia
Shuangmeng Jia
YJYitong Ji
Yitong Ji
YZYingjia Zhu
Yingjia Zhu
YLYishu Lu
Yishu Lu
SLShuaijun Li
Shuaijun Li
Random-pattern skin flaps are widely employed in tissue reconstruction, however, their survival is frequently hindered by ischemia, leading to necrosis. Metabolic alterations have been implicated in playing critical roles in angiogenesis during tissue repair. Using RNA sequencing analysis in a mouse model, we identified significant disruptions in glutamine metabolism, which substantially impaired angiogenesis within random-pattern skin flaps. Although local glutamine repletion failed to alleviate ischemia, administering α-ketoglutarate (α-KG) markedly promoted angiogenesis, as evidenced at both gene and protein levels. In human umbilical vein endothelial cells,α-KG enhanced the stability of hypoxia-inducible factor (HIF-1) alpha through activation of the phosphoinositide 3-kinase (PI3K)-Akt signaling pathway. Notably, α-KG treatment improved flap viability by augmenting blood perfusion, an effect correlated with upregulation of vascular endothelial growth factor expression. Together, these results reveal a novel mechanism by which α-KG enhances random-pattern skin flap viability via promoting angiogenesis through the PI3K/Akt/HIF-1α pathway, offering promising therapeutic insights for improving flap survival.

25 January 2026 in Burns
Verified
Journal Article
Closed access
ZHZihao Hu
Zihao Hu
JHJiefeng Huang
Jiefeng Huang
SCSiyuan Chen
Siyuan Chen
JXJun-Ling Xie
Jun-Ling Xie
SJShuangmeng Jia
Shuangmeng Jia
GLGuangpeng Liu
Guangpeng Liu